Oligonucleotide Synthesis Market
According to Intent Market Research, the Oligonucleotide Synthesis Market is expected to grow from USD 8.1 billion in 2023 at a CAGR of 12.9% to touch USD 19.0 billion by 2030. The Oligonucleotide Synthesis Market is dominated by key players such as Agilent Technologies, Inc., Beckman Coulter, Inc., Bioneer Corporation, Biosearch Technologies, Inc., DNA Script, Eurofins Genomics, GE Healthcare Life Sciences, Illumina, Inc. and Integrated DNA Technologies, Inc.